Talampanel.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics ·Vol. 4 ·No. 1 ·2007-01-00 ·Pages 126-9

Howes JF, Bell C

Abstract

Talampanel is a novel anticonvulsant that acts as an allosteric inhibitor of the AMPA receptor. Talampanel has a broad spectrum of action in animal models of epilepsy and neuroprotection. Clinical experience to date has been able to show effectiveness in reduction of seizures in patients with refractory partial seizures.

MeSH Terms

Animals Antineoplastic Agents Benzodiazepines Brain/drug effects Clinical Trials as Topic Epilepsy/drug therapy Humans

Chemicals

Antineoplastic Agents Benzodiazepines talampanel

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Howes John F

Department of New Drug Development, IVAX Research, Inc., Miami, Florida 33137, USA.

Bell Cynthia

References (21)

21 references, click to expand

Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion.
Stroke. 1989 Aug;20(8):1037-43 PMID: 2756535
Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies.
Neuropharmacology. 1996;35(12):1681-8 PMID: 9076747
Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants.
Pharmazie. 2006 Feb;61(2):125-34 PMID: 16526560
Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy.
Brain Res. 2004 May 22;1008(2):236-44 PMID: 15145761
The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam.
Naunyn Schmiedebergs Arch Pharmacol. 2000 Jun;361(6):629-35 PMID: 10882038
Influence of LY 300164, an AMPA/kainate receptor antagonist upon the anticonvulsant action of antiepileptic drugs against aminophylline-induced seizures in mice.
Pol J Pharmacol. 2003 Jan-Feb;55(1):103-7 PMID: 12856833
Induction of reproducible brain infarction by photochemically initiated thrombosis.
Ann Neurol. 1985 May;17(5):497-504 PMID: 4004172
The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
Brain Res Bull. 2005 Jul 15;66(1):43-9 PMID: 15925143
Unified pharmacogenetics-based parent-metabolite pharmacokinetic model incorporating acetylation polymorphism for talampanel in humans.
J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):377-400 PMID: 16320099
AMPA receptors in epilepsy and as targets for antiepileptic drugs.
Adv Neurol. 1999;79:947-63 PMID: 10514878
Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats.
J Neurotrauma. 2001 Oct;18(10):1031-8 PMID: 11686490
Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy.
Epilepsia. 2003 Jan;44(1):46-53 PMID: 12581229
Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study.
Brain Res Bull. 2006 Jan 15;68(4):269-76 PMID: 16377432
Non-competitive AMPA antagonists of 2,3-benzodiazepine type.
Curr Pharm Des. 2002;8(10):913-39 PMID: 11945139
Immunohistochemical analysis of protein expression after middle cerebral artery occlusion in mice.
Acta Neuropathol. 2004 Feb;107(2):127-36 PMID: 14648078
Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures.
Brain Res Mol Brain Res. 2003 Aug 19;116(1-2):1-6 PMID: 12941455
The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.
Eur J Pharmacol. 1995 Aug 15;281(3):319-26 PMID: 8521916
LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs.
Eur J Pharmacol. 1998 Oct 23;359(2-3):103-9 PMID: 9832379
Glutamate receptors and transporters in genetic and acquired models of epilepsy.
Epilepsy Res. 1999 Sep;36(2-3):189-204 PMID: 10515165
A crossover, add-on trial of talampanel in patients with refractory partial seizures.
Neurology. 2002 Jun 11;58(11):1680-2 PMID: 12058100
Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655.
Brain Res Bull. 2001 Jun;55(3):387-91 PMID: 11489346

Article Info

Journal

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Abbr.

Neurotherapeutics

ISSN

1933-7213

DOI

10.1016/j.nurt.2006.11.001

Published

2007-01-00

Pages

126-9

Language

English

Region

United States

NLM ID

101290381

PMCID

PMC7479696

Subset

External Links

PubMed source DOI: 10.1016/j.nurt.2006.11.001 PMC Full Text View journal details

Analysis Services

Talampanel.

Contact

WeChat Official Account